Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IND
Biotech
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
The agency previously alerted Coya that it would miss the July 30 deadline for a decision on the IND application due to limited resources.
Darren Incorvaia
Aug 25, 2025 11:04am
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
Empress' crown slips as biotech lays off over half of workers
Mar 18, 2025 1:20pm
Affini-T plans to go public in 2024
Jul 25, 2023 2:42pm